FDA: Daytrana patch may cause permanent skin depigmentation
Use of the Daytrana patch (methylphenidate transdermal system) for attention deficit/hyperactivity disorder (ADHD) may result in chemical leukoderma, Food and Drug Administration officials warned in a statement....
Source: Skin and Allergy News - Category: Dermatology Tags: CPN News CPN Child/Adolescent Psychiatry FPN News FPN Child & Adolescent Medicine FPN Mental Health IMN News IMN Mental Health Source Type: news
More News: ADHD | Allergy | Allergy & Immunology | Chemistry | Children | Concerta | Dermatology | Food and Drug Administration (FDA) | Health | Hyperactivity | Men | Methylphenidate | Psychiatry | Ritalin | Skin